German Society for Hematology and Medical Oncology eV / Deutsche Gesellschaft fur Hamatologie und Medizinische Onkologie e.V. (DGHO)

The DGHO (German Society for Hematology and Medical Oncology) is an association of physicians, scientists, and interested parties specializing in the research, diagnosis, and treatment of blood diseases and malignant solid tumors. The DGHO is a rapidly growing professional society with over 4,000 members in one of the most innovative and research-intensive disciplines in medicine.

The German Hematological Society was founded in 1937. The field experienced a boom in the 1970s due to the increasingly successful use of medications to treat malignant diseases such as leukemia and lymphoma. This experience expanded the field to include drug therapy for solid tumors and led to the current name DGHO (German Society for Hematology and Medical Oncology).

The research and treatment of malignant diseases is a major focus of the professional society. The spectrum of activities ranges from basic research and the development of new drugs to clinical trials, the promotion of networks, and health services research. Non-malignant hematological diseases, blood coagulation disorders, laboratory analyses, the entire field of supportive and palliative patient care, nursing, and ethical aspects also play a key role in the DGHO. In more than 30 topic-focused working groups, members are committed to the further development of hematology and medical oncology.